271 related articles for article (PubMed ID: 22160464)
41. Plasmatic estradiol concentration in the mid-luteal phase is a good prognostic factor for clinical and ongoing pregnancies, during stimulated cycles of in vitro fertilization.
Florêncio RS; Meira MSB; Cunha MVD; Camarço MNCR; Castro EC; Finotti MCCF; Oliveira VA
JBRA Assist Reprod; 2018 Mar; 22(1):8-14. PubMed ID: 29338136
[TBL] [Abstract][Full Text] [Related]
42. Effect of Endometrium Thickness on Clinical Outcomes in Luteal Phase Short-Acting GnRH-a Long Protocol and GnRH-Ant Protocol.
Zhang J; Sun YF; Xu YM; Shi BJ; Han Y; Luo ZY; Zhao ZM; Hao GM; Gao BL
Front Endocrinol (Lausanne); 2021; 12():578783. PubMed ID: 34079517
[TBL] [Abstract][Full Text] [Related]
43. Letrozole and gonadotropins versus luteal estradiol and gonadotropin-releasing hormone antagonist protocol in women with a prior low response to ovarian stimulation.
Elassar A; Engmann L; Nulsen J; Benadiva C
Fertil Steril; 2011 Jun; 95(7):2330-4. PubMed ID: 21514582
[TBL] [Abstract][Full Text] [Related]
44. Luteal phase oestradiol administration in ovarian stimulation cycles with GnRH antagonist is comparable to the GnRH agonist (long) protocol.
Cunha Filho JS; Terres LF; Holanda F; Freitas F; Glitz C; Genro VK; Arbo E
J Assist Reprod Genet; 2007 Aug; 24(8):326-30. PubMed ID: 17636446
[TBL] [Abstract][Full Text] [Related]
45. Value of estrogen pretreatment in patients with diminished ovarian reserve and elevated FSH on a line antagonist regimen: a retrospective controlled study.
Lin L; Chen G; Liu Y
J Ovarian Res; 2024 May; 17(1):114. PubMed ID: 38802887
[TBL] [Abstract][Full Text] [Related]
46. ANDRO-IVF: a novel protocol for poor responders to IVF controlled ovarian stimulation.
Bercaire L; Nogueira SM; Lima PC; Alves VR; Donadio N; Dzik A; Cavagna M
JBRA Assist Reprod; 2018 Mar; 22(1):52-55. PubMed ID: 29303236
[TBL] [Abstract][Full Text] [Related]
47. Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
Fatemi HM; Polyzos NP; van Vaerenbergh I; Bourgain C; Blockeel C; Alsbjerg B; Papanikolaou EG; Humaidan P
Fertil Steril; 2013 Sep; 100(3):742-7. PubMed ID: 23806846
[TBL] [Abstract][Full Text] [Related]
48. Luteal Phase Ovarian Stimulation May Improve Oocyte Retrieval and Oocyte Quality in Poor Ovarian Responders Undergoing In Vitro Fertilization: Preliminary Results from a Single-Center Prospective Pilot Study.
Lin LT; Vitale SG; Chen SN; Wen ZH; Tsai HW; Chern CU; Tsui KH
Adv Ther; 2018 Jun; 35(6):847-856. PubMed ID: 29869107
[TBL] [Abstract][Full Text] [Related]
49. Cycle day 2 insulin-like growth factor-1 serum levels as a prognostic tool to predict controlled ovarian hyperstimulation outcomes in poor responders.
Man L; Lekovich J; Canon C; Rosenwaks Z; James D
Fertil Steril; 2020 Jun; 113(6):1205-1214. PubMed ID: 32482254
[TBL] [Abstract][Full Text] [Related]
50. Impact of clomiphene citrate during ovarian stimulation on the luteal phase after GnRH agonist trigger.
Derksen L; Tournaye H; Stoop D; Van Vaerenbergh I; Bourgain C; Polyzos NP; Haentjens P; Blockeel C
Reprod Biomed Online; 2014 Mar; 28(3):359-68. PubMed ID: 24456700
[TBL] [Abstract][Full Text] [Related]
51. Programming in vitro fertilization retrievals during working days after a gonadotropin-releasing hormone antagonist protocol with estrogen pretreatment: does the length of exposure to estradiol impact on controlled ovarian hyperstimulation outcomes?
Guivarc'h-Levêque A; Homer L; Arvis P; Broux PL; Moy L; Priou G; Vialard J; Colleu D; Dewailly D
Fertil Steril; 2011 Oct; 96(4):872-6. PubMed ID: 21868004
[TBL] [Abstract][Full Text] [Related]
52. Cumulative Live Birth Rate and Cost-Effectiveness Analysis of Gonadotropin Releasing Hormone-Antagonist Protocol and Multiple Minimal Ovarian Stimulation in Poor Responders.
Liu Y; Su R; Wu Y
Front Endocrinol (Lausanne); 2020; 11():605939. PubMed ID: 33519714
[TBL] [Abstract][Full Text] [Related]
53. Towards an optimal luteal support modality in agonist triggered cycles: a randomized clinical trial.
Elgindy EA; Sibai H; Mostafa MI; Gibreel A; Darwish E; Maghraby H
Hum Reprod; 2018 Jun; 33(6):1079-1086. PubMed ID: 29562260
[TBL] [Abstract][Full Text] [Related]
54. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
[TBL] [Abstract][Full Text] [Related]
55. GnRH agonist versus HCG triggering in different IVF/ICSI cycles of same patients: a retrospective study.
Yılmaz N; Ceran MU; Ugurlu EN; Gülerman HC; Engin Ustun Y
J Obstet Gynaecol; 2020 Aug; 40(6):837-842. PubMed ID: 31791167
[TBL] [Abstract][Full Text] [Related]
56. The best execution of the DuoStim strategy (double stimulation in the follicular and luteal phase of the same ovarian cycle) in patients who are poor ovarian responders.
Luo Y; Sun L; Dong M; Zhang X; Huang L; Zhu X; Nong Y; Liu F
Reprod Biol Endocrinol; 2020 Oct; 18(1):102. PubMed ID: 33059712
[TBL] [Abstract][Full Text] [Related]
57. Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation?
Kedem A; Tsur A; Haas J; Yerushalmi GM; Hourvitz A; Machtinger R; Orvieto R
Fertil Steril; 2014 Jun; 101(6):1624-8. PubMed ID: 24680364
[TBL] [Abstract][Full Text] [Related]
58. Follicular synchronization using transdermal estradiol patch and GnRH antagonists in the luteal phase; does it increase oocyte yield in poor responders to gonadotropin stimulation for in vitro fertilization (IVF)? A comparative study with microdose flare-up protocol.
Ata B; Zeng X; Son WY; Holzer H; Tan SL
Gynecol Endocrinol; 2011 Nov; 27(11):876-9. PubMed ID: 21495800
[TBL] [Abstract][Full Text] [Related]
59. Retrospective comparison of GnRH agonist trigger with HCG trigger in GnRH antagonist cycles in anticipated high-responders.
Datta AK; Eapen A; Birch H; Kurinchi-Selvan A; Lockwood G
Reprod Biomed Online; 2014 Nov; 29(5):552-8. PubMed ID: 25246126
[TBL] [Abstract][Full Text] [Related]
60. Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS.
Lainas GT; Kolibianakis EM; Sfontouris IA; Zorzovilis IZ; Petsas GK; Lainas TG; Tarlatzis BC
Hum Reprod; 2013 Jul; 28(7):1929-42. PubMed ID: 23624582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
